Clinical trial / 2004
Pomegranate juice ellagitannins were not absorbed intact in healthy adults but were metabolized by colonic microflora into dibenzopyranone derivatives.
Six healthy adults drank 1 L of pomegranate juice daily for 5 days to assess ellagitannin bioavailability, blood parameters, and antioxidant activity. Neither punicalagin nor ellagic acid were detected in plasma or urine; instead, three colonic microflora-derived metabolites were found, reaching up to 18.6 microM in plasma with urine excretion ranging from 0.7 to 52.7% of ingested punicalagin. No relevant effect was observed on any blood parameter, and the metabolites lacked significant antioxidant activity compared to punicalagin.
- Study type
- Interventional study
- Who was studied
- 6 healthy subjects (4 men and 2 women)
- What was measured
- Bioavailability and metabolism of ellagitannins, blood hematological/serobiochemical parameters, and in vitro antioxidant activity
THE PAPER
The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.
Cerdá B, Espín JC, Parra S, Martínez P, Tomás-Barberán FA. Eur J Nutr, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.